Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
1/2025
vol. 27
 
Share:
Send email
Share:
Review paper

Insulin resistance as a challenge to general practitioners

Marzena Jabczyk
1
,
Justyna Nowak
2
,
Natalia Zięba
3
,
Bartosz Hudzik
2
,
Barbara Zubelewicz-Szkodzińska
1, 4

  1. Department of Nutrition-Related Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia
  2. Department of Cardiovascular Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia
  3. Student Scientific Circle Affiliated of Department of Metabolic Disease Prevention, Faculty of Public Health in Bytom, Medical University of Silesia, Bytom, Poland
  4. Department of Endocrinology, District Hospital, Piekary Slaskie, Poland
Family Medicine & Primary Care Review 2025; 27(1): 113–117
DOI: https://doi.org/10.5114/fmpcr.2025.146979
Online publish date: 2025/03/26
Article file
- 17 FM&PCR 1 25 - R - Jabczyk - 1618 - Insulin resistance.pdf  [0.49 MB]
Get citation
 
PlumX metrics:
 
1. Sasaki N, Ueno Y, Higashi Y. Indicators of insulin resistance in clinical practice. Hypertens Res 2024; 47(4): 978–980.
2. Freeman AM, Acevedo LA, Pennings N. Insulin Resistance. In: StatPearls [Internet]. Treasure Island (FL); 2025.
3. Nolan CJ, Prentki M. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. Diab Vasc Dis Res 2019; 16(2): 118–127, doi: 10.1177/1479164119827611.
4. Ramírez-Manent JI, Jover AM, Martinez CS, et al. Waist Circumference Is an Essential Factor in Predicting Insulin Resistance and Early Detection of Metabolic Syndrome in Adults. Nutrients 2023; 4; 15(2): 257, doi: 10.3390/nu15020257.
5. Lytrivi M, Castell AL, Poitout V, et al. Recent Insights into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes. J Mol Biol 2020; 432: 1514–1534, doi: 10.1016/j.jmb.2019.09.016.
6. Cifarelli V, Appak-Baskoy S, Peche VS, et al. Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells. Nat Commun 2021; 12: 3350, doi: 10.1038/s41467-021-23808-3.
7. Smith GI, Shankaran M, Yoshino M, et al. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Investig 2020; 130: 1453–1460, doi: 10.1172/JCI134165.
8. Thomas DD, Corkey BE, Istfan NW, et al. Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction. J Endocr Soc 2019; 24; 3(9): 1727–1747, doi: 10.1210/js.2019-00065.
9. Polymeris A, Papapetrou PD. Anthropometric indicators of insulin resistance. Hormones (Athens) 2022; 21(1): 51–52, doi: 10.1007/s42000-021-00296-0.
10. Rasouli N, Molavi B, Elbein SC, et al. Ectopic fat accumulation and metabolic syndrome. Diabetes Obes Metab 2007; 9: 1–10.
11. Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 2008; 93: 57–63.
12. Yang W, Jin C, Wang H, et al. Subclinical hypothyroidism increases insulin resistance in normoglycemic people. Front Endocrinol (Lausanne) 2023; 6(14): 1106968, doi: 10.3389/fendo.2023.1106968.
13. Adone A, Fulmali DG. Polycystic Ovarian Syndrome in Adolescents. Cureus 2023; 25; 15(1): e34183, doi: 10.7759/cureus.34183.
14. Zhao X, An X, Yang C, et al. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol (Lausanne) 2023; 14: 1149239, doi: 10.3389/fendo.2023.1149239.
15. Tahapary DL, Pratisthita LB, Fitri NA, et al. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr 2022; 16(8): 102581, doi: 10.1016/j.dsx.2022.102581.
16. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in hu-mans. Arch Intern Med 2008; 168: 1609–1616.
17. Kang ES, Yun YS, Park SW, et al. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metabolism 2005; 54(2): 206–211, doi: 10.1016/j.metabol.2004.08.014.
18. Seyedhoseinpour A, Barzin M, Mahdavi M, BMI category-specific waist circumference thresholds based on cardi-ovascular disease outcomes and all-cause mortality: Tehran lipid and glucose study (TLGS). BMC Public Health 2023; 23(1): 1297, doi: 10.1186/s12889-023-16190-w.
19. Minh HV, Tien HA, Sinh CT, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens (Greenwich) 2021; 23(3): 529–537, doi: 10.1111/jch.14155.
20. Zhou D, Liu XC, Kenneth L, et al. A Non-Linear Association of Triglyceride Glycemic Index with Cardiovascular and All-Cause Mortality Among Patients with Hypertension. Front Cardiovasc Med 2022; 8: 778038, doi: 10.3389/fcvm.2021.778038.
21. Nogueira-de-Almeida CA, Veiga F, Contin AA, et al. Anthropometric Indicators of Body Composition Associated with Lipid and Glycemic Profiles in Overweight Brazilian Children and Adolescents From 2008 to 2020. Front Nutr 2022; 9: 908562.
22. Li R, Li Q, Cui M, et al. Clinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese. J Diabetes Investig 2018; 9: 411–418, doi: 10.1111/jdi.12708.
23. Murai N, Saito N, Oka R, et al. Body Roundness Index Is Better Correlated with Insulin Sensitivity than Body Shape Index in Young and Middle-Aged Japanese Persons. Metab Syndr Relat Disord 2024; 22(2): 151–159, doi: 10.1089/met.2023.0175.
24. Jabłonowska-Lietz, Wrzosek M, Włodarczyk M, et al. New indexes of body fat distribution, visceral adiposity in-dex, body adiposity index, waist-to-height ratio, and metabolic disturbances in the obese. Kardiol Pol 2017; 75(11):1185–1191.
25. Saneei P, Shahdadian F, Moradi S, et al. Neck circumference in relation to glycemic parameters: a systematic re-view and meta-analysis of observational studies. Diabetol Metab Syndr 2018; 75(11): 50–65.
26. Tsai SF, Yang CT, Liu WJ, et al. Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. Clinical Medicine 2023; 58: 101934, doi: 10.1016/j.eclinm.2023.101934.
27. Rokicka G, Wiśniewska K, Okręglicka K. Eating habits among women with insulin resistance (IR) on a vegetarian vs non-vegetarian diet. Fam Med Prim Care Rev 2022; 24(4): 336–340, doi: 10.5114/fmpcr.2022.120858.
28. Kosmas CE, Bousvarou MD, Kostara CE, et al. Insulin resistance and cardiovascular disease. J Int Med Res 2023; 51(3): 3000605231164548, doi: 10.1177/03000605231164548.
29. Marson EC, Delevatti RS, Prado AK, et al. Effects of aerobic, resistance, and combined exercise training on insulin resistance markers in overweight or obese children and adolescents: A systematic review and meta-analysis. Prev Med 2016; 93: 211–218, doi: 10.1016/j.ypmed.2016.10.020.
30. Flores-Guerrero JL, Been RA, Shalaurova I, et al. Triglyceride/HDL cholesterol ratio and lipoprotein insulin resistance Score: Associations with subclinical atherosclerosis and incident cardiovascular disease. Clin Chim Acta 2024; 553: 117737, doi: 10.1016/j.cca.2023.117737.
31. Hosseinpour-Niazi S, Afaghi S, Hadaegh P, et al. The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status. J Diabetes Investig 2024; 15(2): 208–218, doi: 10.1111/jdi.14101.
32. Zhou D, Liu XC, Kenneth L, et al. A Non-Linear Association of Triglyceride Glycemic Index with Cardiovascular and All-Cause Mortality Among Patients with Hypertension. Front Cardiovasc Med 2022; 8: 778038, doi: 10.3389/fcvm.2021.778038.
33. Genazzani AD, Genazzani AR. Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance. touchREV Endocrinol 2023; 19(1): 71–77, doi: 10.17925/EE.2023.19.1.71.
34. Biernacka-Bartnik A, Kocełak P, Owczarek AJ, et al. The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome. Front Med (Lausanne) 2023; 10: 1100547, doi: 10.3389/fmed.2023.1100547.
35. Mousa S, Saif A, Fathy M, et al. Assessment of early vascular changes in adult females with polycystic ovary syn-drome: correlation with insulin resistance. Gynecol Endocrinol 2023; 39(1): 2210226, doi: 10.1080/09513590.2023.
36. Arduc A, Sarıcam O, Dogan BA, et al. Should insulin resistance be screened in lean hirsute women? Gynecol Endo-crinol 2015; 31(4): 291–295, doi: 10.3109/09513590.2014.994598.
37. Amiri M, Mahmoudieh L, Sheidaei A, et al. Insulin resistance and idiopathic hirsutism: A systematic review, meta-analysis, and meta-regression. J Cosmet Dermatol 2022; 21(11): 5346–5359, doi: 10.1111/jocd.15070.
38. Zeng P, Xiangsheng C, Xiaozhou Y, et al. HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population. J Int Med Res 2023; 51(10): 03000605231204462.
39. Mantovani A, Byrne CD, Bonora E, et al. Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care 2018; 41(2): 372–382.
40. Chatterjee A, Basu A, Das K. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcohol-ic fatty liver disease pathogenesis. Ann Hepatol 2020; 19(5): 472–481.
41. Khan RS, Bril F, Cusi K, et al. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology 2019; 70(2): 711–724.
42. Dae-Seok K, Scherer PE. Obesity, Diabetes, and Increased Cancer Progression. Diabetes Metab J 2021; 45(6): 799–812.
43. Watson KT, Simard JF, Henderson VW, et al. Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study. Am J Psychiatry 2021; 178(10): 914–920, doi: 10.1176/appi.ajp.2021.20101479.
44. Bauermeister SD, Jehudy MD, Reida G, et al. Insulin resistance, age and depression’s impact on cognition in middle-aged adults from the PREVENT cohort. BMJ Ment Health 2023; 26(1): e300665, doi: 10.1136/bmjment-2023-300665.
Copyright: © 2025 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.